Papers

1

Total Citations

64

H-Index

1

About

A. Arcelli is a leading clinical researcher whose work centers on the application of stereotactic body radiotherapy (SBRT) for challenging gastrointestinal malignancies, with a particular focus on pancreatic cancer. Her most influential contribution is a landmark systematic review on the role of SBRT for pain relief in locally advanced pancreatic carcinoma (LAPC), which has garnered 64 citations. This work critically established that beyond its primary goal of tumor control, SBRT serves as a powerful tool for symptom palliation, offering significant pain reduction in a disease with notoriously poor prognosis. By synthesizing evidence on this emerging technique, Arcelli demonstrated that radiotherapy can meaningfully improve quality of life for LAPC patients, a population often limited to survival-prolonging measures. Her research bridges the gap between oncologic efficacy and palliative care, highlighting SBRT's dual benefit. Through this systematic review and related studies, Arcelli has helped shape clinical guidelines for managing pancreatic cancer, providing a foundation for integrating advanced radiotherapy into multidisciplinary treatment paradigms and improving outcomes for patients facing this aggressive disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
64
Total Citations
64
Avg Citations/Paper
🏆 Most Cited Paper
Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
64 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago